GU Cancer Clinical Trials

DISCLAIMER: All content found on cua.org is provided for information and education purposes. The medical information and clinical trials information is not intended to substitute for the advice of a physician, nor is it intended to provide legal advice. You should always consult your doctor for specific information on personal health matters, or other relevant professionals to ensure that your own circumstances are considered.

The CUA is not responsible in any manner for direct, indirect, special or consequential damages caused and/or arising from your use of cua.org.

Subspecialty
Renal | ON | Recruiting
18-5481
SABR for Renal Tumors
Dr. Joelle Helou
Start Date: November 1, 2018

NCT #:  NCT03747133

SPONSOR: University Health Network

INFO: https://clinicaltrials.gov/ct2/show/NCT03747133?recrs=abf&cond=Renal+Cell+Carcinoma&cntry=CA&draw=2&rank=19

CONTACT:  416-946-4501 x 4866

OTHER CANADIAN CENTRES: Royal Victoria Regional Health Centre (Barrie)

 

Prostate | ON | Recruiting
PREP
PSMA-PET Registry for Recurrent Prostate Cancer (PREP)
Dr. Glen Bauman
Start Date: September 27, 2018

NCT #: NCT03718260

INFO:  https://clinicaltrials.gov/ct2/show/NCT03718260

CONTACT:  Catherine Hildebrand // 519-685-8500 ext 53535

Prostate | BC | Recruiting
LDR/HDRmono
LDR vs. HDR Brachytherapy for Prostate Cancer
Dr. Juanita Crook
Start Date: February 15, 2018

NCT #: NCT03426748

SPONSOR: British Columbia Cancer Agency in collaboration with BC Cancer Foundation

INFO: https://clinicaltrials.gov/ct2/show/NCT03426748

CONTACT:  Dr. Juanita Crook (Kelowna)
Phone:250-712-3958             
Email: jcrook@bccancer.bc.ca

OTHER CANADIAN CENTRES: Kelowna, British Columbia

Penile | ON | Recruiting
ALPACA
A Study of Avelumab in Penile Cancer Who Are Unfit for or Have Progressed After Platinum-Based Chemotherapy
Dr. Srikala Sridhar
Start Date: January 5, 2018

NCT #: NCT03391479

SPONSOR: University Health Network, Toronto

INFO: https://classic.clinicaltrials.gov/ct2/show/NCT0339147

CONTACT: Dr. Srikala Sridhar: srikala.sridhar@uhn.ca

Prostate | BC | Recruiting
SalvageHDR
Partial Prostate Salvage High Dose Rate Brachytherapy (SalvageHDR)
Dr. Juanita Crook
Start Date: January 1, 2018

NCT #: NCT03246802

SPONSOR: British Columbia Cancer Agency

INFO: https://clinicaltrials.gov/study/NCT03246802

CONTACT: Dr. Juanita Crook (Kelowna)
Phone: 250-712-3958                 
Email: jcrook@bccancer.bc.ca

OTHER CANADIAN CENTRES: Kelowna, British Columbia

Prostate | AB, BC, NS, ON, QC, SK | Recruiting
1234G
A Phase II Study of Carboplatin in Patients with Metastatic Castration-Resistant Prostate Cancer
Dr. Zineb Hamilou (CHUM)
Start Date: December 12, 2017

NCT #: NCT03385655

INFO: https://clinicaltrials.gov/ct2/show/NCT03385655

CONTACT:

(514) 890-8000 Ext. 20688

Prostate | AB, BC, NS, ON, QC, SK | Recruiting
1234C
A Phase II Study of Darolutamide (ODM-201) in Patients with Metastatic Castration-Resistant Prostate Cancer Previously Treated with Abiraterone Acetate or Enzalutamide - A Sub-Study of IND.234
Dr. Michael Ong (OHRI)
Start Date: December 12, 2017

INFO:: https://clinicaltrials.gov/ct2/show/NCT03385655

CONTACT:  (613) 737-7700 Ext. 75051

Prostate | AB, BC, NS, ON, QC, SK | Recruiting
1234B
A Randomized Phase II Trial Evaluating the Impact of SBRT with or without Nirapariib in Patients with Metastatic Hormone Sensitive Prostate Cancer Treated with ADT and Androgen Axis Directed Therapy
Dr. Som Mukherjee (JCC)
Start Date: December 12, 2017

CONTACT:

(905) 387-9495 Ext. 64605

Prostate | AB, BC, NS, ON, QC, SK | Recruiting
1234
Prostate Cancer Biomarker Enrichment and Treatment Selection (PC_BETS) Study - Master Screening Protocol
Dr. Kim Chi (Vancouver)
Start Date: December 12, 2017

NCT#: NCT03385655

INFO: https://clinicaltrials.gov/ct2/show/NCT03385655

CONTACT:

(604) 877-6000 Ext. 2746

 

 

Bladder | ON, QC | Active, not recruiting
EV-103
A Study of Enfortumab Vedotin Alone or With Other Therapies for Treatment of Urothelial Cancer
Start Date: October 11, 2017

NCT #: NCT03288545

SPONSOR: Merck, Seagen

INFO: https://www.clinicaltrials.gov/ct2/show/NCT03288545

CONTACT: Astellas in collaboration with Merck and Seagen Inc.

OTHER CANADIAN CENTRES:

1. Brampton Civic Hospital - William Osler (Brampton, ON)

2. Kingston General Hospital (Kingston, ON)

3.  UHN: Princess Margaret Cancer Centre (Toronto, ON)

4. Jewish General Hospital (Montreal, QC)

5. McGill University Health Centre (Montreal, QC)

6. Hopital Fleurimont (CHUS) (Sherbrooke, QC)

The Canadian Urological Association (CUA) does not provide professional medical advice, diagnosis or treatment and cannot respond to requests for direct feedback, specific patient information or physician referrals. You should first always seek the advice of your urologist, physician and other qualified health provider with any questions regarding your medical condition. The contents of the CUA Website such as text, graphics, images, and other content are for informational purposes only. The content/information is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on the CUA website.

For comments or information, email Corporate.office@cua.org

Privacy Policy